Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Innovative Surgical Sciences|June 26, 2025
Deep learning for automated boundary detection and segmentation in organ donation photographyGeorgios Kourounis, Ali Ahmed Elmahmudi, Brian Thomson, et al.
Pregnancy Hypertension|April 23, 2023
Pre-eclampsia is associated with complement pathway activation in the maternal and fetal circulation, and placental tissueHannah Blakey, Ruyue Sun, Long Xie, et al.
Blood|June 27, 2023
Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort studyVicky Brocklebank, Patrick R Walsh, Kate Smith-Jackson, et al.
International Journal of Molecular Sciences|August 27, 2021
MiR-126-3p Is Dynamically Regulated in Endothelial-to-Mesenchymal Transition during FibrosisNina P Jordan, Samuel J Tingle, Victoria G Shuttleworth, et al.
The New England Journal of Medicine|May 12, 2006
Influence of donor C3 allotype on late renal-transplantation outcomeKatherine M Brown, Elli Kondeatis, Robert W Vaughan, et al.
The Lancet Regional Health. Europe|January 19, 2026
Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trialAndrew Bryant, Jan Lecouturier, Giovany Orozco-Leal, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 21, 2021
MicroRNA antagonist therapy during normothermic machine perfusion of donor kidneysEmily R Thompson, Avinash Sewpaul, Rodrigo Figuereido, et al.
Transplantation|April 18, 2020
KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney TransplantationSteven J Chadban, Curie Ahn, David A Axelrod, et al.
BMJ Open|September 19, 2024
SIGNET: protocol for a multicentre, single-blind prospective, group sequential, randomised controlled trial to evaluate the benefits of a single dose of simvastatin given to potential organ donors declared dead by neurological criteria on outcomes in organ recipientsAmy Evans, Phil Mawson, Helen Thomas, et al.
Health Technology Assessment (Winchester, England)|March 3, 2026
Clinical and cost-effectiveness of eculizumab withdrawal in atypical haemolytic uraemic syndrome: the SETS aHUS multi-centre, open-label, prospective and single-arm studyAndrew Bryant, Jan Lecouturier, Giovany Orozco-Leal, et al.
Pageof 8